FdaApplication
ANDA 090252
Identifiers
- fda_app_no: ANDA090252
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2013-08-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REPAGLINIDE | REPAGLINIDE | 1MG | TABLET;ORAL |
| REPAGLINIDE | REPAGLINIDE | 0.5MG | TABLET;ORAL |
| REPAGLINIDE | REPAGLINIDE | 2MG | TABLET;ORAL |
3 products